← FDA DRUG APPROVALS

FDA ANDA · ANDA090463

PERINDOPRIL ERBUMINE

Sponsor: APOTEX

APPLICATION
ANDA090463
TYPE
ANDA
ORIGINAL APPROVAL
2010-08-30
LATEST ACTION
2015-04-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PERINDOPRIL ERBUMINEDiscontinued
PERINDOPRIL ERBUMINE 4MG · TABLET · ORAL
PERINDOPRIL ERBUMINEDiscontinued
PERINDOPRIL ERBUMINE 8MG · TABLET · ORAL
PERINDOPRIL ERBUMINEDiscontinued
PERINDOPRIL ERBUMINE 2MG · TABLET · ORAL

Approval history

2015-04-15Labeling · Supplement 1 · standardAP
2010-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →